Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Sep;38(9):773-776.
doi: 10.13201/j.issn.2096-7993.2024.09.001.

[Review and prospect of the diagnosis and treatment of head and neck paragangliomas]

[Article in Chinese]
Shankai Yin  1
Affiliations
Review

[Review and prospect of the diagnosis and treatment of head and neck paragangliomas]

[Article in Chinese]
Shankai Yin. Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2024 Sep.

Abstract
in English, Chinese

ead and neck paraganglioma（HNPGL） often originates from the parasympathetic ganglia and is a highly invasive benign tumor. The diagnosis and treatment of this disease with strong heterogeneity is still a challenge. In the future, deep exploration is needed in genetic typing, grading diagnosis and treatment decisions, protection of cranial nerves and new drug treatments to better treat this disease.

摘要：头颈部副神经节瘤多起源于副交感神经节，是一种侵袭性较强的良性肿瘤。对于这一类异质性较强的疾病的诊治目前仍是挑战。未来需要在遗传学分型、分级诊疗决策、保护颅神经及新型药物治疗等方面深入探索，以期更好的治疗该疾病。.

Keywords: diagnosis; head and neck paragangliomas; treatment.

PubMed Disclaimer

Conflict of interest statement

The authors of this article and the planning committee members and staff have no relevant financial relationships with commercial interests to disclose.

References

    1. Sandow L, Thawani R, Kim MS, et al. Paraganglioma of the head and neck: a review. Endocr Pract. 2023;29(2):141–147. doi: 10.1016/j.eprac.2022.10.002. - DOI - PMC - PubMed
    1. Burnichon N, Brière JJ, Libé R, et al. SDHA is a tumor suppressor gene causing paraganglioma. Hum Mol Genet. 2010;19(15):3011–3020. doi: 10.1093/hmg/ddq206. - DOI - PMC - PubMed
    1. Fishbein L, Merrill S, Fraker DL, et al. Inherited mutations in pheochromocytoma and paraganglioma: why all patients should be offered genetic testing. Ann Surg Oncol. 2013;20(5):1444–1450. doi: 10.1245/s10434-013-2942-5. - DOI - PMC - PubMed
    1. Hensen EF, Siemers MD, Jansen JC, et al. Mutations in SDHD are the major determinants of the clinical characteristics of Dutch head and neck paraganglioma patients. Clin Endocrinol. 2011;75(5):650–655. doi: 10.1111/j.1365-2265.2011.04097.x. - DOI - PubMed
    1. Welander J, Söderkvist P, Gimm O. Genetics and clinical characteristics of hereditary pheochromocytomas and paragangliomas. Endocr Relat Cancer. 2011;18(6):R253–R276. doi: 10.1530/ERC-11-0170. - DOI - PubMed

MeSH terms

LinkOut - more resources